Prestige Biologics Co., Ltd. (KOSDAQ:334970)
South Korea
· Delayed Price · Currency is KRW 3,235.00
+15.00 (0.47%)
At close: Dec 5, 2025
Prestige Biologics Revenue
Prestige Biologics had revenue of 1.17B KRW in the quarter ending September 30, 2025, with 241.37% growth. This brings the company's revenue in the last twelve months to 13.36B, up 736.63% year-over-year. In the fiscal year ending June 30, 2025, Prestige Biologics had annual revenue of 12.53B with 477.83% growth.
Revenue (ttm)
13.36B
Revenue Growth
+736.63%
P/S Ratio
18.83
Revenue / Employee
n/a
Employees
n/a
Market Cap
251.53B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 12.53B | 10.36B | 477.83% |
| Jun 30, 2024 | 2.17B | 423.21M | 24.24% |
| Jun 30, 2023 | 1.75B | 1.73B | 11,115.88% |
| Dec 31, 2022 | 15.57M | -3.21B | -99.52% |
| Dec 31, 2021 | 3.23B | - | - |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Electronics | 315.56T |
| SK hynix | 84.09T |
| LG Energy Solution | 23.98T |
| Samsung Biologics | 5,504.84B |
| Hyundai Motor Company | 186.04T |
| Doosan Enerbility | 16.79T |
| HD Hyundai Heavy Industries | 16.39T |
| KB Financial Group | 14.89T |